Table 2.
Question | Latin America (n=2,169) | Argentina (n=436) | Brazil (n=400) | Mexico (n=532) | Puerto Rico (n=401) | Venezuela (n=400) |
---|---|---|---|---|---|---|
Daytime symptom frequency, % |
|
|
|
|
|
|
Every day/most days |
24 |
35 |
27 |
12 |
34 |
18 |
1-2 days/week |
22 |
25 |
20 |
20 |
15 |
29 |
1-2 times/month |
11 |
8 |
10 |
18 |
7 |
11 |
No daytime symptoms |
44 |
32 |
44 |
50 |
43 |
42 |
Nighttime symptom frequency, % |
|
|
|
|
|
|
Every night/most nights |
20 |
28 |
24 |
9 |
26 |
14 |
1-2 nights/week |
16 |
20 |
16 |
16 |
15 |
18 |
1-2 times/month |
10 |
8 |
11 |
12 |
5 |
10 |
No nighttime symptoms |
53 |
45 |
50 |
62 |
53 |
58 |
Subjects with episodes in the past 12 months with asthma symptoms more frequent or more severe than normal, % |
47 |
57 |
46 |
42 |
61 |
48 |
Median number of episodes |
2 |
3 |
2 |
3 |
3 |
3 |
Subjects who agreed with the following statements, % |
|
|
|
|
|
|
Long-term control medicines should be taken every day |
41 |
61 |
41 |
48 |
61 |
26 |
Long-term control medicines are not necessary when asthma symptoms are not experienced regularly |
65 |
55 |
67 |
54 |
59 |
72 |
Quick relief medications can be used every day if needed |
61 |
68 |
58 |
56 |
84 |
71 |
Subjects reporting ≥1 week of interrupted asthma controller medicine use, % |
|
|
|
|
|
|
<2 weeks |
26 |
32 |
26 |
29 |
15 |
21 |
3-4 weeks |
9 |
10 |
8 |
14 |
9 |
10 |
≥1 month |
61 |
49 |
52 |
52 |
71 |
65 |
GINA 2009 asthma control levels |
|
|
|
|
|
|
Well controlled, % |
8 |
5 |
9 |
9 |
8 |
3 |
Partly controlled, % |
57 |
48 |
57 |
56 |
59 |
65 |
Uncontrolled, % | 35 | 57 | 34 | 35 | 33 | 32 |
GINA=Global initiative for asthma.